Acute myeloid leukemia (AML) is an aggressive blood cancer in which abnormal, immature cells build up in the bone marrow, disrupting the production of healthy blood cells. Now, a new study, led by Dr. José Luis Sardina's group at the Josep Carreras Leukaemia Research Institute (IJC), examines how two systems that help control normal blood cell development are connected: the chemical marks on DNA and the regulation of RNA, which carries instructions for making proteins. The work is published in the journal Science Advances.
New Insights into Acute Myeloid Leukemia: Linking DNA and RNA Regulation
A new study led by Dr. José Luis Sardina at the Josep Carreras Leukaemia Research Institute explores the connection between DNA chemical marks and RNA regulation in the context of acute myeloid leukemia (AML). This research could have implications for cancer treatment and understanding blood disorders. While not directly related to Iran, advancements in medical research can impact global health, including in Iran.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%